争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 2 条
2021
巴黎法院裁定施维雅在Mediator案中有罪并处以罚款
裁决
巴黎法院裁定施维雅在减肥药Mediator相关案件中犯有过失杀人和欺诈罪,并对公司处以270万欧元罚款。
品牌回应
澄清 — Servier
Servier said in an emailed statement it was analyzing the decision and would decide upon what further action to take in the coming days.
来源摘录
France’s health ministry has said that at least 500 people died of heart valve problems in France because of exposure to the active ingredient in Mediator, a drug which was withdrawn from sale in 2009.
PARIS — A Paris court on Monday found French drugmaker Servier guilty of manslaughter and deception over weight-loss pill Mediator, and fined the company 2.7 million euros ($3.18 million), according to a copy of the ruling seen by Reuters.
Servier said in an emailed statement it was analyzing the decision and would decide upon what further action to take in the coming days.
2009
Mediator药物安全丑闻
Mediator是施维雅(Servier)销售的一种苯氟雷司药物,在引发严重心脏瓣膜和肺动脉高压风险的担忧后于法国撤市。该事件引发了监管调查、赔偿程序和刑事诉讼。2021年,巴黎一家法院在主要刑事案件中判定施维雅犯有加重欺诈和过失杀人罪。